Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee, Dariusz Woszczyk, Jae-Yong Kwak, Stella Bowcock, Sang Kyun Sohn, Gabriela Rodríguez Macias, Tzeon-Jye Chiou, Dimas Quiel, Mickaël Aoun, María Belén Navarro Matilla, Javier de la Serna, Samuel T. Milliken, John Murphy, Shelly McNeil, Bruno Salaun, Emmanuel Di Paolo, Laura Cámpora, Marta López‐Fauqued, Mohamed El Idrissi, Anne Schuind, Thomas C. Heineman, Peter van Steen, Lidia Oostvogels, Kadir Acar, Boris V. Afanasyev, Aránzazu Alonso Alonso, Veli‐Jukka Anttila, Pere Barba, Norbert Blesing, Terrance Comeau, M. T. del Campo, Patricia Disperati, Richard Eek, Hyeon‐Seok Eom, Gianluca Gaïdano, Sebastian Grosicki, Thierry Guillaume, Wojciech Homenda, William Ying Khee Hwang, Nikolay Ilyin, Anna Johnston, Seok Jin Kim, Ching-Yuan Kuo, А Ю Кувшинов, Dong‐Gun Lee, Jae Hoon Lee, Je‐Jung Lee, Stéphane Leprêtre, Albert Kwok-Wai Lie, Alessandro Lucchesi, Ahmed Ijaz Masood, Naheed Mir, Carolina Miranda, Kathleen M. Mullane, Alexandr Myasnikov, Raquel Oña Navarrete, Karlis Pauksens, Andrew Peniket, Jaime Pérez de Oteyza, David Pohlreich, Humphrey Pullon, Philippe Quittet, Philippe Rodon, Lars Rombo, Olga Samoylova, Johan Berglund, Ariah Schattner, Dominik Selleslag, Marjatta Sinisalo, Faisal Sultan, Koen Theunissen, Paul Turner, Po-Nan Wang, Lucrecia Yáñez, Jo‐Anne H. Young, Pierre Zachée, Francesco Zaja

The Lancet Infectious Diseases, 2019